IL49996A0 - Solution of an oxazepine for oral or parenteral administration - Google Patents

Solution of an oxazepine for oral or parenteral administration

Info

Publication number
IL49996A0
IL49996A0 IL49996A IL4999676A IL49996A0 IL 49996 A0 IL49996 A0 IL 49996A0 IL 49996 A IL49996 A IL 49996A IL 4999676 A IL4999676 A IL 4999676A IL 49996 A0 IL49996 A0 IL 49996A0
Authority
IL
Israel
Prior art keywords
oxazepine
oral
solution
parenteral administration
parenteral
Prior art date
Application number
IL49996A
Other versions
IL49996A (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL49996A0 publication Critical patent/IL49996A0/en
Publication of IL49996A publication Critical patent/IL49996A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
IL49996A 1975-08-06 1976-07-08 Solution of a solubilized and stabilized 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine for oral or parenteral adminstration IL49996A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60233175A 1975-08-06 1975-08-06

Publications (2)

Publication Number Publication Date
IL49996A0 true IL49996A0 (en) 1976-09-30
IL49996A IL49996A (en) 1981-01-30

Family

ID=24410918

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49996A IL49996A (en) 1975-08-06 1976-07-08 Solution of a solubilized and stabilized 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine for oral or parenteral adminstration

Country Status (19)

Country Link
JP (1) JPS5221313A (en)
AR (1) AR210501A1 (en)
AT (1) AT345464B (en)
AU (1) AU500641B2 (en)
BE (1) BE844903A (en)
CA (1) CA1069823A (en)
DE (1) DE2633943A1 (en)
DK (1) DK147727C (en)
EG (1) EG12425A (en)
ES (1) ES450520A1 (en)
FI (1) FI762171A (en)
FR (1) FR2320102A1 (en)
GB (1) GB1546933A (en)
IL (1) IL49996A (en)
NL (1) NL7608575A (en)
NO (1) NO146457C (en)
PT (1) PT65400B (en)
SE (1) SE431716B (en)
ZA (1) ZA764052B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739254B1 (en) * 1995-09-29 1997-12-19 Rhone Merieux PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
FR2739255B1 (en) * 1995-09-29 1998-09-04 Rhone Merieux PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
WO2010106325A2 (en) 2009-03-18 2010-09-23 Omnipharm Limited Parasiticidal formulation

Also Published As

Publication number Publication date
IL49996A (en) 1981-01-30
AU1577576A (en) 1978-01-12
CA1069823A (en) 1980-01-15
NO146457C (en) 1982-10-06
DK354076A (en) 1977-02-07
FR2320102A1 (en) 1977-03-04
AR210501A1 (en) 1977-08-15
AU500641B2 (en) 1979-05-31
BE844903A (en) 1977-02-07
FI762171A (en) 1977-02-07
DK147727C (en) 1985-06-17
EG12425A (en) 1979-06-30
NO762713L (en) 1977-02-08
GB1546933A (en) 1979-05-31
SE7608810L (en) 1977-02-07
DK147727B (en) 1984-11-26
NO146457B (en) 1982-06-28
JPS5221313A (en) 1977-02-17
ES450520A1 (en) 1978-05-01
DE2633943A1 (en) 1977-02-17
SE431716B (en) 1984-02-27
ZA764052B (en) 1977-06-29
PT65400A (en) 1976-08-01
AT345464B (en) 1978-09-25
ATA581376A (en) 1978-01-15
NL7608575A (en) 1977-02-08
PT65400B (en) 1978-01-27

Similar Documents

Publication Publication Date Title
ZA764096B (en) Benzylidene derivatives
ZA765469B (en) N-thiolcarbonyl derivatives of (-phosphono-methylglycine
GB1549836A (en) Process for the preparation of diazepine derivatives
AU2015876A (en) Parenteral administration set
JPS5237176A (en) Ampule
JPS51136772A (en) Preparation of high ciss1*44polybutadiene
JPS51130521A (en) Stabilisation of redused betaanicotineamideeadenineedinucleotide
IL49996A0 (en) Solution of an oxazepine for oral or parenteral administration
MY8400030A (en) Cephalos porins containing an alkylsulphonylamino group
IL49686A0 (en) Preparation of 3-phenoxybenzaldehydes
JPS5218810A (en) Complex medical composition of estrogennprostaglangin
IL50634A0 (en) Preparation of 2-amino-1-alcohols
JPS5277083A (en) Nnacyl derivatives of thienamycine
GB1487036A (en) Pharmaceutically useful 2-aminoacetoamido-alpha-phenylbenzylideneaminoalkanol derivatives
IL50150A (en) Preparation of 3-methoxymethyl-cephalosporins
GR58471B (en) Preparation process of diazepin derivatives
JPS5259695A (en) Preparation of copolymer
JPS5276309A (en) Tublar refractories
IL49120A (en) Preparation of n-alkenyl-2-aminomethyl-pyrrolidines
HK29981A (en) Preparation of gamma-pyrones
IL50192A (en) Production of 3-acyl oxazolidines
JPS5273882A (en) Preparation of 22substitutedd55 fluoropyrimidinee44one derivatives
JPS51120016A (en) Connection portion of unit residence
JPS51122033A (en) Preparation of symmetric diarylsulphide
JPS5273883A (en) Preparation of 55fluoropyrimidinee44one derivatives